Chairman

Hemanshu Shah is an executive with more than 30 years’ experience, in both large pharmaceutical companies and emerging biotechnology companies including BMS, Astellas, Innate and Johnson & Johnson. Hemanshu has experience across multiple functional areas including drug development, strategic marketing, business development and commercial operations (US and global marketing), with a focus in the oncology therapeutic area.

Hemanshu has a PhD in Pharmaceutical Sciences from Rutgers University (NJ, USA) and an MBA from the University at Buffalo (NY, USA).